li001

Zirconium Nanoparticles Boost Photodynamic Therapy in the Fight Against Cancer

Zirconium oxide nanoparticles are being used to improve photodynamic therapy (PDT) for cancer. PDT is a minimally invasive treatment that relies on a light-activated drug and oxygen to produce reactive oxygen species that kill cancer cells. While effective in theory, traditional PDT is limited by poor drug solubility, shallow light penetration, and low oxygen levels […]

Zirconium Nanoparticles Boost Photodynamic Therapy in the Fight Against Cancer Read More »

Electric Pulse Therapy Offers New Hope for Hard-to-Treat Pancreatic Cancer

High-voltage electrical pulses (HVEPs) are being used as a non-heat-based treatment for pancreatic cancer. HVEPs work by applying strong electric fields that create tiny pores in cancer cell membranes, a process called electroporation. Lower electric fields temporarily increase cell permeability and make tumors more sensitive to drugs, while stronger fields cause permanent damage that leads

Electric Pulse Therapy Offers New Hope for Hard-to-Treat Pancreatic Cancer Read More »

PROTAC Drugs Signal a New Era of Cancer Treatment by Destroying Disease-Driving Proteins

PROTAC technology represents a major shift in modern drug design, moving beyond protein inhibition toward directly eliminating disease-causing proteins. Unlike traditional drugs that must block a specific active site, PROTACs work by guiding unwanted proteins to the cell’s natural disposal system. Once the protein is tagged and destroyed, the PROTAC molecule is released and can

PROTAC Drugs Signal a New Era of Cancer Treatment by Destroying Disease-Driving Proteins Read More »

Nanotechnology Reshapes Cancer Treatment by Targeting the Tumor’s Hidden Defenses

advanced nanotechnology-based therapies, with a focus on how tumors protect themselves through the tumor microenvironment (TME). Conventional treatments like chemotherapy, radiation, and surgery often struggle because they lack precision, harm healthy cells, and have difficulty reaching advanced tumors. Despite decades of use, these methods have only modestly improved survival rates for late-stage cancers, highlighting the

Nanotechnology Reshapes Cancer Treatment by Targeting the Tumor’s Hidden Defenses Read More »

“Smart” Hydrogels Offer New Hope for Hard-to-Treat Pancreatic Cancer

Pancreatic cancer is one of the deadliest cancers because it is usually found late and is difficult to treat. Most patients cannot have surgery, and even those who do often see the cancer return. The tumor is surrounded by a dense, fibrous barrier that blocks drugs from reaching cancer cells and creates an environment that

“Smart” Hydrogels Offer New Hope for Hard-to-Treat Pancreatic Cancer Read More »

Key Cancer Stem Cells Found to Drive Chemotherapy Resistance in Pancreatic Cancer

Researchers have identified a small but powerful group of pancreatic cancer cells that are responsible for resistance to gemcitabine, the most commonly used chemotherapy for the disease. These cells, known as cancer stem cells, are marked by high levels of a protein called ARPC1B. Unlike other tumor cells, they can survive treatment and regenerate the

Key Cancer Stem Cells Found to Drive Chemotherapy Resistance in Pancreatic Cancer Read More »

Rethinking Fibroblasts: How Tumor Support Cells Shape Pancreatic Cancer Treatment

Pancreatic cancer is hard to treat because it is surrounded by dense supportive tissue that blocks chemotherapy. The most abundant cells in this tissue are cancer-associated fibroblasts (CAFs), which strongly influence how tumors grow, spread, and resist treatment. Rather than being just passive barriers, CAFs actively shape the tumor environment. Researchers have found that CAFs

Rethinking Fibroblasts: How Tumor Support Cells Shape Pancreatic Cancer Treatment Read More »

Pancreatic Cancer Found to Hijack Nerve Signals to Drive Tumor Growth and Pain

Researchers have uncovered that pancreatic cancer cells and nearby sensory nerves help each other grow stronger through a chemical signal called glutamate. Sensory nerves release glutamate, and pancreatic cancer cells have a receptor called GRIN2D that detects it. High levels of GRIN2D are linked to more advanced cancer. When cancer cells sense glutamate, they become more

Pancreatic Cancer Found to Hijack Nerve Signals to Drive Tumor Growth and Pain Read More »

Personalized Approaches and KRAS Inhibitors Transform Pancreatic Cancer Treatment

Treatment for metastatic pancreatic cancer is becoming more personalized, moving away from a “one-size-fits-all” approach. Doctors now consider patient age, side-effect tolerance, and tumor genetics, such as KRAS mutations, when selecting therapy. NALIRIFOX, approved in 2024, is now a key first-line option. In the NAPOLI 3 trial, it reduced the risk of death by 16%

Personalized Approaches and KRAS Inhibitors Transform Pancreatic Cancer Treatment Read More »

Metastatic Tumor Biopsies Better Predict Immunotherapy Success in Ovarian Cancer

New data from the NeoPembrOV/GINECO trial show that in high-grade serous ovarian cancer, testing PD-L1 levels in metastatic tumors predicts response to immunotherapy better than testing the primary tumor. Patients with high PD-L1 in metastatic sites had a 54% lower risk of disease progression when treated with pembrolizumab plus chemotherapy, while primary tumor PD-L1 was

Metastatic Tumor Biopsies Better Predict Immunotherapy Success in Ovarian Cancer Read More »